VMD Valuation

Viemed Healthcare Inc

Add to Watchlist

Advanced Chart

6.800

-0.01(-0.147%)1D

Overview
Forecast
Valuation
Earnings

VMD Relative Valuation

VMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VMD is overvalued; if below, it's undervalued.

Historical Valuation

Viemed Healthcare Inc (VMD) is now in the Fair zone, suggesting that its current forward PE ratio of 18.41 is considered Fairly compared with the five-year average of 27.65. The fair price of Viemed Healthcare Inc (VMD) is between 6.72 to 11.36 according to relative valuation methord.

Relative Value

Fair Zone

6.72-11.36

Current Price：6.80

Fair

18.41

Trailing

Forward

3.94

EV/EBITDA

Viemed Healthcare Inc. (VMD) has a current EV/EBITDA of 3.94. The 5-year average EV/EBITDA is 7.34. The thresholds are as follows: Strongly Undervalued below 2.15, Undervalued between 2.15 and 4.75, Fairly Valued between 9.94 and 4.75, Overvalued between 9.94 and 12.53, and Strongly Overvalued above 12.53. The current Forward EV/EBITDA of 3.94 falls within the Undervalued range.

10.36

EV/EBIT

Viemed Healthcare Inc. (VMD) has a current EV/EBIT of 10.36. The 5-year average EV/EBIT is 20.79. The thresholds are as follows: Strongly Undervalued below 4.48, Undervalued between 4.48 and 12.63, Fairly Valued between 28.95 and 12.63, Overvalued between 28.95 and 37.11, and Strongly Overvalued above 37.11. The current Forward EV/EBIT of 10.36 falls within the Undervalued range.

0.85

Viemed Healthcare Inc. (VMD) has a current PS of 0.85. The 5-year average PS is 1.73. The thresholds are as follows: Strongly Undervalued below 0.44, Undervalued between 0.44 and 1.08, Fairly Valued between 2.37 and 1.08, Overvalued between 2.37 and 3.02, and Strongly Overvalued above 3.02. The current Forward PS of 0.85 falls within the Undervalued range.

0.00

P/OCF

Viemed Healthcare Inc. (VMD) has a current P/OCF of 0.00. The 5-year average P/OCF is 4.79. The thresholds are as follows: Strongly Undervalued below -5.12, Undervalued between -5.12 and -0.17, Fairly Valued between 9.74 and -0.17, Overvalued between 9.74 and 14.70, and Strongly Overvalued above 14.70. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Viemed Healthcare Inc. (VMD) has a current P/FCF of 0.00. The 5-year average P/FCF is 11.79. The thresholds are as follows: Strongly Undervalued below -12.29, Undervalued between -12.29 and -0.25, Fairly Valued between 23.82 and -0.25, Overvalued between 23.82 and 35.86, and Strongly Overvalued above 35.86. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Viemed Healthcare Inc (VMD) has a current Price-to-Book (P/B) ratio of 1.93. Compared to its 3-year average P/B ratio of 2.72 , the current P/B ratio is approximately -29.02% higher. Relative to its 5-year average P/B ratio of 2.94, the current P/B ratio is about -34.44% higher. Viemed Healthcare Inc (VMD) has a Forward Free Cash Flow (FCF) yield of approximately -1.36%. Compared to its 3-year average FCF yield of 2.23%, the current FCF yield is approximately -161.24% lower. Relative to its 5-year average FCF yield of 2.91% , the current FCF yield is about -146.93% lower.

1.93

P/B

Median3y

2.72

Median5y

2.94

-1.36

FCF Yield

Median3y

2.23

Median5y

2.91

Competitors Valuation Multiple

The average P/S ratio for VMD's competitors is 0.36, providing a benchmark for relative valuation. Viemed Healthcare Inc Corp (VMD) exhibits a P/S ratio of 0.85, which is 136.71% above the industry average. Given its robust revenue growth of 14.72%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

VMD.O

Viemed Healthcare Inc

Community Health Systems Inc

Select Medical Holdings Corp

National Healthcare Corp

Performance Decomposition

Market capitalization of VMD decreased by 7.09% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 2.69 to 5.15.

The secondary factor is the Revenue Growth, contributed 14.72%to the performance.

Overall, the performance of VMD in the past 1 year is driven by Margin Expansion. Which is more sustainable.

14.72%

54.97M → 63.06M

Revenue Growth

91.45%

2.69 → 5.15

Margin Expansion

-113.26%

-151.72 → 20.12

P/E Change

-7.09%